Stock Options: Choosing The Right Viral Inoculum For An Early-Phase Norovirus Trial

One daysingle sourceOne outlet reported this, once - no second voice in this corpus.

All 1 reports on Thu, 20 August 2026

What it is about

Cocrystal Pharma Sam Lee Abby Proch Nadine Rouphael Emory University University Of Northa Carolina

Who published it, and when

How it spread - 1 original report

Thu, 20 August 2026
1 report
- clinicalleader.com08:45first to report
  Stock Options: Choosing The Right Viral Inoculum For An Early-Phase Norovirus Trial
  Viral stock can make or break a norovirus challenge study. Cocrystal Pharmas Sam Lee explains why inoculum quality, infectivity, and availability matter.